PREPARATION AND EVALUATION OF STARCH PHOSPHATE- A NEW MODIFIED STARCH AS A DISINTEGRANT IN TABLET FORMULATIONS



Similar documents
SODIUM CARBOXYMETHYL CELLULOSE

STARCH Application Data

Research Article Prospective Validation of Paracetamol Tablet Dosage Form

Asian Journal of Research in Biological and Pharmaceutical Sciences Journal home page:

Formulation and Evaluation of Didanosine Enteric Coated Sustained Release Tablet

Tamsulosin Hydrochloride Capsules

Vinod et al., ARPB, 2013; Vol 3 (II) ISSN

It is an important tool to assess factors that affect the bioavailability of a drug from a solid preparartion.

High Performance Dry Binding with CELNY-SSL Super Fine Powder

Reversed Phase High Presssure Liquid Chromatograhphic Technique for Determination of Sodium Alginate from Oral Suspension

Table 1. Pure superdisintegrant tablet formulation. Material % w/w Weight (mg) Superdisintegrant Stearic acid 1 2.

High Performance Dry Binding with HPC-SSL Super Fine Powder

FORMULATION EVALUATION AND OPTIMIZATION OF AN ORAL IMMEDIATE RELEASE ANTIBIOTIC FORMULATION OF AMOXICILLINE

Journal of Chemical and Pharmaceutical Research

Use of bromophenol blue in the spectrophotometric and turbidimetric determination of mebrophenhydramine in tablets

POLYVINYL ALCOHOL. SYNONYMS Vinyl alcohol polymer, PVOH, INS No DEFINITION DESCRIPTION FUNCTIONAL USES CHARACTERISTICS

Performance Evaluation of Actimask 92S Ibuprofen: A Novel Taste-Masked Ibuprofen for Use in Orally-Dispersible Dosage Forms

THE PHARMACEUTICAL INDUSTRY

PECTINS. SYNONYMS INS No. 440 DEFINITION DESCRIPTION. FUNCTIONAL USES Gelling agent, thickener, stabilizer, emulsifier CHARACTERISTICS

LUMEFANTRINE Draft proposal for The International Pharmacopoeia (October 2006)

POLYDIMETHYLSILOXANE

CHARACTERIZATION AND EVALUATION OF OKRA GUM AS A TABLET BINDER

Separation by Solvent Extraction

The importance of normalisation when comparing tablet properties

QbD Understanding How Excipient Properties Influence Solid Oral Dosage Form Performance

α-cyclodextrin SYNONYMS α-schardinger dextrin, α-dextrin, cyclohexaamylose, cyclomaltohexaose, α- cycloamylase

HEXANES. Insoluble in water, soluble in ether, alcohol, and acetone. Neutral to methyl orange (ph indicator) Not more than 0.

All the prepared formulations were subjected for following. evaluation parameters and obtained results were showed in Tables 6.3 &

High Performance Thin Layer Chromatographic Method for Estimation of Cefprozil in Tablet Dosage Form

Experiment 8 Synthesis of Aspirin

ERDOSTEINE - MONOGRAPH.

Directly compressed mini-tablets coated in a solid-wall pan for sustained drug release

KARL FISCHER ELECTROMETRIC TITRATION METHOD FOR DETERMINATION OF WATER CONTENT

ACID-BASE TITRATIONS: DETERMINATION OF CARBONATE BY TITRATION WITH HYDROCHLORIC ACID BACKGROUND

SUCRALOSE. White to off-white, practically odourless crystalline powder

Name Lab #3: Solubility of Organic Compounds Objectives: Introduction: soluble insoluble partially soluble miscible immiscible

Alharith Hassan. Q 10 Method of Shelf-life estimation. Methods of Chemical stabilisation 11/20/2015

2.3 QUALITY OVERALL SUMMARY Sakura Tablet

Solid dosage forms testing: Disintegration test and tablet friability and hardness

Journal of Chemical and Pharmaceutical Research, 2012, 4(7): Research Article

POWDER PROPERTIES LABORATORY

TEACHER ACTIVITY GUIDE

PART I SIEVE ANALYSIS OF MATERIAL RETAINED ON THE 425 M (NO. 40) SIEVE

CHEM 2423 Recrystallization of Benzoic Acid EXPERIMENT 4 - Purification - Recrystallization of Benzoic acid

INTERNATIONAL JOURNAL OF PHARMACY & LIFE SCIENCES Formulation and evaluation of intragastric buoyant tablets of amoxicillin trihydrate

BRIEFING Plastic Packaging Systems for Pharmaceutical Use.

Experiment 7: Titration of an Antacid

EUDRAGIT E 100, EUDRAGIT E PO and

Determination of calcium by Standardized EDTA Solution

TANNIC ACID. SYNONYMS Tannins (food grade), gallotannic acid, INS No. 181 DEFINITION DESCRIPTION

HPLC Analysis of Acetaminophen Tablets with Waters Alliance and Agilent Supplies

experiment5 Understanding and applying the concept of limiting reagents. Learning how to perform a vacuum filtration.

CERTIFICATE OF ANALYSIS Methyl 4-Hydroxybenzoate

MOISTURE (Karl Fischer, Buffered)

The identification of tablets and capsules containing barbiturates by MATR infrared spectroscopy

Comparative Assessment of the Quality Control Measurements of Multisource Ofloxacin Tablets Marketed in Nigeria

I. ACID-BASE NEUTRALIZATION, TITRATION

Organic Chemistry Lab Experiment 4 Preparation and Properties of Soap

Phosphorus, colorimetry, phosphomolybdate, automated-segmented flow

Development of validated RP- HPLC method for estimation of rivaroxaban in pharmaceutical formulation

DRINKING WATER - LAB EXPERIMENTS. Coagulation and flocculation LAB EXPERIMENTS. Jartest

Apparatus error for each piece of equipment = 100 x margin of error quantity measured

Experiment #10: Liquids, Liquid Mixtures and Solutions

PRODUCT DEVELOPMENT GUIDE

Phosphorus, Reactive (Orthophosphate)

Chemistry 112 Laboratory Experiment 6: The Reaction of Aluminum and Zinc with Hydrochloric Acid

Aquagent. Pyridine-free volumetric Karl Fischer reagents

RESEARCH ARTICLE PREPARATION AND EVALUATION OF LEVOFLOXACIN HEMIHYDRATES FLOATING TABLETS

IN VITRO BINDING BIOEQUIVALENCE STUDY SUMMARY TABLES AND SAS TRANSPORT FORMATTED TABLES FOR DATASET SUBMISSION

In this experiment, we will use three properties to identify a liquid substance: solubility, density and boiling point..

FOR PLANT PROTECTION PRODUCTS FOOD AND AGRICULTURE ORGANIZATION OF THE UNITED NATIONS

6 Characterization of Casein and Bovine Serum Albumin

GENERAL GUIDANCE FOR INSPECTORS ON HOLD-TIME STUDIES

C-100E Strong Acid Cation Exchange Resin (For use in water softening applications)

KINETIC DETERMINATION OF SELENIUM BY VISIBLE SPECTROSCOPY (VERSION 1.8)

SIMULTANEOUS DETERMINATION OF TELMISARTAN AND HYDROCHLOROTHIAZIDE IN TABLET DOSAGE FORM USING REVERSE PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY

ISOLATION OF CAFFEINE FROM TEA

HiPer Ion Exchange Chromatography Teaching Kit

To measure the solubility of a salt in water over a range of temperatures and to construct a graph representing the salt solubility.

UV-VIS SPECTROPHOTOMETRIC METHOD FOR ESTIMATION OF GABAPENTIN AND METHYLCOBALAMIN IN BULK AND TABLET

CHEMICAL PRECIPITATION: WATER SOFTENING

FAO SPECIFICATIONS FOR PLANT PROTECTION PRODUCTS FOOD AND AGRICULTURE ORGANIZATION OF THE UNITED NATIONS

3.4 TEST FOR BACTERIAL ENDOTOXINS. Final text for revision of The International Pharmacopoeia

Quality by Design for ANDAs: An Example for Modified Release Dosage Forms

Generic Drug Formulations. with. and. Kollidon SR

ENE 806, Project Report 3 CHEMICAL PRECIPITATION: WATER SOFTENING. Grégoire Seyrig Wenqian Shan

Analytical Test Report

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE

A Beer s Law Experiment

Drospirenone and Ethinyl Estradiol Tablets. Type of Posting. Revision Bulletin Posting Date. 31 July 2015 Official Date

Factors Affecting Enzyme Activity

ß-CYCLODEXTRIN SYNONYMS

Acids & Bases: Using Purple Cabbage as a ph indicator. Grade 9 Activity Plan

Effect of Filler Type on the Stability of Polyethylene Oxide in a Hydrophilic Matrix Tablet

Process Validation Protocol (Reference: SOP )

PROTEINS (LOWRY) PROTOCOL

Experiment #8 properties of Alcohols and Phenols

EXPERIMENT # 3 ELECTROLYTES AND NON-ELECTROLYTES

Molar Mass of Polyvinyl Alcohol by Viscosity

Transcription:

Int. J. Chem. Sci.: 9(2), 2011, 889-899 Int. J. Chem. Sci.: ISSN 9(1), 0972-768X 2011, 1-11 www.sadgurupublications.com PREPARATIN AND EVALUATIN F STARCH PHSPHATE- A NEW MDIFIED STARCH AS A DISINTEGRANT IN TABLET FRMULATINS K. P. R. CHWDARY *, VEERAIAH ENTURI and A. SANDHYA RANI University College of Pharmaceutical Sciences, Andhra University, VISAKHAPATNAM 530003 (A.P.) INDIA ABSTRACT Starch phosphate prepared by reacting potato starch with di-sodium hydrogen orthophosphate anhydrous at elevated temperatures was found to be a white, crystalline, non-hygroscopic powder. Starch phosphate prepared exhibited excellent flow characteristics. Starch phosphate was insoluble in water and aqueous fluids of acidic and alkaline phs. It also exhibited good swelling (400%) in water. It has no pasting or gelling property when heated at 100 o C in water for 30 min. As starch phosphate exhibited good swelling in water, it is considered as a promising disintegrant in tablet formulations and was evaluated as disintegrant in tablet formulations. Tablets of (i) sulfamethoxazole (100 mg) and (ii) paracetamol (120 mg) were prepared by wet granulation method employing starch phosphate at 5 and 10% strength as disintegrant and were evaluated. For comparison tablets were also prepared employing crospovidone (a super disintegrant) as disintegrant at 5 and 10% strength in the tablets. Paracetamol and sulfamethoxazole tablets formulated employing starch phosphate (both wet and dry addition) disintegrated within 3 min. Wet addition of starch phosphate gave relatively fast disintegration than dry addition with both the drugs. Paracetamol and sulfamethoxazole tablets formulated employing starch phosphate as disintegrant gave rapid and higher dissolution of the contained drug when compared to those formulated with crospovidone and commercial product in each case. Wet addition of starch phosphate gave relatively faster dissolution with both the drugs than dry addition. Thus starch phosphate, a new modified starch, was found to be a promising disintegrant in tablet formulations and can be used in a concentration of 5-10% as an efficient disintegrant. Key words: Modified starch, Starch phosphate, Disintegrant, Tablets, Sulfamethoxazole, Paracetamol. INTRDUCTIN Disintegrant is critical ingredient in tablets. Disintegration and subsequent dissolution are the rate limiting steps in the absorption of a poorly soluble drug administered * Author for correspondence; E-mail: prof.kprchowdary@rediffmail.com

890 K. P. R. Chowdary et al.: Preparation and Evaluation. in a tablet dosage form. Though several disintegrants such as native starches, modified starches and cellulose derivatives are available, there is a continued need to develop new, safe and effective disintegrants for tablets. The objective of the present study is to prepare and evaluate starch phosphate, a new chemically modified starch as a disintegrant in tablets. Starch and modified starches such as sodium starch glycolate (Primogel), pregelatinized starch, dextrin and cyclodextrins have been used in tablets and capsules as fillers, disintegrants and dry binders. Starch citrate, a chemically modified starch has been reported 1 as disintegrant in tablet formulations. Starch phosphate is one of the modified starches used in the frozen food industry 2,3. It is produced by phosphorification of free hydroxyl groups of anhydroglucose units of starch molecule. They are esterified with phosphate reagents. Phosphate reagents for starch phosphate monoester are orthophosphate salts 4. Starch phosphate production is normally by using wet process 2. No reports are available on its use as pharmaceutical excipient. In the present study, starch phosphate is prepared, characterised and evaluated as disintegrant in tablets prepared by granulation method. Tablets of (i) sulfamethoxazole (100 mg) and (ii) paracetamol (120 mg) were prepared by wet granulation method incorporating starch phosphate as disintegrant at 5 and 10% strength in the formula. In each case starch phosphate was added before granulation (wet addition) and after granulation (dry addition). For comparison sulfamethoxazole and paracetamol tablets were also prepared employing crospovidone, a super disintegrant. The tablets prepared were evaluated in comparison to commercial brands in each case. The results are presented in this paper. Materials and methods EXPERIMENTAL Sulfamethoxazole, paracetamol and crospovidone were gift samples from M/s Natco Pharma Ltd, Hyderabad. Potato Starch and di-sodium hydrogen orthophosphate anhydrous (Qualigens) were procured from commercial sources. All other materials used were of pharmacopoeial grade. Preparation of starch phosphate Starch phosphate was prepared based on the method of Choi et al. 5 with some modifications. Potato starch (100 g) and di-sodium hydrogen orthophosphate anhydrous (30 g) were suspended in 100 ml of water and continuously stirred for 20 min. This starch slurry was then filtered and the wet starch mixture was conditioned for 12 h at room

Int. J. Chem. Sci.: 9(2), 2011 891 temperature (28 o C). To enhance phosphorylation, this mixture was heated in a forced air oven at 130 o C for 3 h. The product obtained was grounded and sized. Characterization of starch phosphate Solubility The starch phosphate prepared was evaluated for following : Solubility of starch phosphate was tested in water, aqueous buffers of ph 1.2, 4.5, and 7.4 and organic solvents such as alcohol, dichloromethane, chloroform, acetone and petroleum ether. ph Melting point Viscosity The ph of a 1% w/v slurry was measured. Melting point was determined by using melting point apparatus. Viscosity of 1% dispersion in water was measured using stwald Viscometer. Swelling index Starch phosphate (200 mg) was added to 10 ml of water and light liquid paraffin taken in two different graduated test tubes and mixed. The dispersion in the tubes were allowed to stand for 12 h. The volumes of the sediment in the tubes were recorded. The swelling index of the material was calculated as follows. Volume of sediment in water - Volume of sediment in light liquid paraffin S.I = Volume of sediment in light liquid paraffin Test for Gelling property x 100 The gelling property (gelatinization) of the starch and starch phosphate prepared was evaluated by heating a 7% w/v dispersion of each in water at 100 o C for 30 min. Moisture absorption The hygroscopic nature of starch phosphate was evaluated by moisture absorption studies in a closed desiccator at 84% relative humidity and room temperature.

892 K. P. R. Chowdary et al.: Preparation and Evaluation. Particle size Density liquid. Bulk density Particle size analysis was done by sieving using standard sieves. Density (g/cc) was determined by liquid displacement method using benzene as Bulk density (g/cc) was determined by three tap method in a graduated cylinder. Angle of repose Angle of repose was measured by fixed funnel method. Compressibility index Compressibility index (CI) was determined by measuring the initial volume (V o ) and final volume (V) after hundred tappings of a sample of starch phosphate in a measuring cylinder. CI was calculated using equation Compressibility index (CI) = V o V x 100 V o Preparation of tablets Tablets of (i) sulfamethoxazole (100 mg) and (ii) paracetamol (120 mg) were prepared by conventional wet granulation method employing acacia (2%) as a binder, lactose (q.s) as diluent, talc (2%) and magnesium stearate (2%) as lubricants and water as granulating fluid. Starch phosphate was included in the formulations as disintegrant at 5 and 10% strength in each case. For comparison tablets were also prepared employing crospovidone (a super disintegrant) as disintegrant at 5 and 10% strength in the tablets. Two series of tablets were made in each case. In one series starch phosphate was added before granulation (wet addition) and in the other series it was added after drying the granules and before compression (dry addition). The granules were compressed into tablets on a tablet punching machine (M/s Cadmach Machinery Co. Pvt. Ltd) to a hardness of 7 kg/cm 2 using 9 mm round and flat punches. In each case 100 tablets were compressed. Evaluation of tablets Hardness of tablets was tested using Monsanto Hardness tester. Friability of the

Int. J. Chem. Sci.: 9(2), 2011 893 tablets was determined in a Roche friabilator. Disintegration time was determined in a Thermonic tablet disintegration test machine using water as test fluid. Estimation of drug content in the tablets From each batch of tablets prepared five tablets were accurately weighed and powdered. Tablet powder equivalent to 20 mg of drug was taken for assay into a 100 ml conical flask and extracted with 3 x 10 ml quantities of methanol. The methanolic extracts were filtered and collected into a 50 ml volumetric flask and the volume was made upto 50 ml with methanol. The solution was then suitably diluted with 0.1 N hydrochloric acid in the case of sulfamethoxazole and with phosphate buffer of ph 7.8 in the case of paracetamol. The absorbance of the solutions was measured at 265 nm for sulfamethoxazole and at 249 nm for paracetamol. Drug content of the tablets were calculated using the standard calibration curve in each case. Dissolution rate study Dissolution rate of the tablets prepared was studied using 8 station dissolution rate apparatus (M/s Lab India Disso 2000) employing a paddle stirrer at 50 rpm and at 37 + 1 o C. Hydrochloric acid 0.1 N (900 ml) was used as dissolution fluid for sulfamethoxazole and Phosphate buffer of ph 7.8 (900 ml) was used as dissolution fluid in the case of paracetamol tablets. Samples of dissolution fluid, 5 ml each, were withdrawn at 5, 10, 15, 20, 25, 30, 40, 50, 60 min. through a filter (0.45 µ). The samples were suitably diluted with the corresponding dissolution fluid and assayed for sulfamethoxazole at 265 nm and paracetamol at 249 nm using the corresponding dissolution fluid as blank. Each sample withdrawn was replaced with an equal amount of drug free dissolution fluid. All dissolution experiments were conducted in triplicate. RESULTS AND DISCUSSIN Starch phosphate was prepared by reacting starch with di-sodium hydrogen orthophosphate anhydrous at elevated temperatures. The reactions involved are shown in Fig. 1. Starch phosphate prepared was found to be white, crystalline, non hygroscopic powder and can easily be grounded to different sizes. Powder which passes through mesh No. 80 and retained on mesh No. 120 was collected. This powder has an average particle size of 152 µm. The starch phosphate prepared was characterised by determining various physical properties. The properties of starch phosphate prepared are summarised in Table 1.

894 K. P. R. Chowdary et al.: Preparation and Evaluation. Na P H Na2HP4 ph 5, 3 h, 130 o C H H H H 2 H H Fig. 1: Phosphorification of potato starch to produce starch phosphate Table 1: Physical properties of the starch phosphate prepared Property Result Solubility Insoluble in all aqueous and organic solvents tested ph (1% w/v aqueous dispersion) 7.25 Melting Point Charred at 210 o C Viscosity (1% w/v aqueous 2.11 cps dispersion) Swelling index 400 Gelling property No gelling and the swollen particles of starch phosphate separated from water. Whereas in the case of starch, it was gelatinized and formed gel. Moisture absorption 4.0 % Particle size 152 µm (80/120 mesh) Density 1.667 g/cc Bulk density 0.534 g/cc Angle of repose 20.04 0 Compressibility index 11.01 % When tested for m.p., it was charred at 210 o C. Starch phosphate prepared was insoluble in water, aqueous fluids of acidic and alkaline ph and several organic solvents tested. In water it exhibited good swelling (400%). No gelling/pasting was observed with starch phosphate when its aqueous dispersion was heated at 100 o C for 30 min, where as

Int. J. Chem. Sci.: 9(2), 2011 895 potato starch formed a paste/gel during the above heat treatment. In the micromeritic evaluation, the angle of repose and compressibility index values revealed the excellent flow characteristic of starch phosphate. As starch phosphate exhibited good swelling in water it is considered as a promising disintegrant in tablet formulations and was evaluated as disintegrant in tablet formulations. Tablets of (i) sulfamethoxazole (100 mg) and (ii) paracetamol (120 mg) were prepared by wet granulation method employing starch phosphate at 5 and 10% strength as disintegrant in each case. In one series starch phosphate was added before granulation (wet addition) and in another series it was added after drying the granules and before compression (dry addition) to evaluate starch phosphate as disintegrant in both the methods. All the tablets were evaluated for weight variation, drug content, hardness, friability, disintegration time and dissolution rate and dissolution efficiency. For comparison commercial brands in each case were also evaluated. The physical properties of all the tablets formulated as well as commercial brands tested are given in Tables 2 and 3. Table 2: Drug content, hardness, friability, disintegration time of paracetamol tablets formulated employing starch phosphate and crospovidone as disintegrant Disintegrant Starch Phosphate Crospovidone Type of addition & concentration Drug content Hardness Friability Disintegration time (Wet/Dry) (mg/tab) (Kg/cm 2 ) (min-sec) Wet (5%) 118.9 6.5 1.4 3-0 Wet (10%) 119.2 5.5 0 1-30 Dry (5%) 119.1 6.0 0 2-0 Dry (10%) 119.4 6.5 1.1 1-14 Wet (5%) 119.7 5.5 1.0 0-37 Wet (10%) 119.3 6.5 1.5 0-25 Dry (5%) 119.5 5.5 2.7 2-04 Dry (10%) 119.5 6.0 0.88 0-42 Commercial - 119.4 6.5 1.05 1-21 In the test for uniformity of weight the percentage deviation was less than 4.5% in all the cases. Drug content was within 100 + 3% of the labelled claim in each case. Hardness of

896 K. P. R. Chowdary et al.: Preparation and Evaluation. the formulated tablets was in the range 5.5-7.5 Kg/cm 2. Weight loss in the friability test was less than 2.70%. All the formulated tablets including both wet and dry addition of starch phosphate, disintegrated within 3 min. Wet addition of starch phosphate gave relatively fast disintegration than dry addition with both the drugs. Paracetamol tablets formulated employing crospovidone were also disintegrated within 2 min. Whereas sulfamethoxazole tablets formulated employing crospovidone exhibited relatively slow disintegration (Table 3). As such, all tablets formulated employing starch phosphate were of good quality with regard to weight variation, hardness, friability and drug content and disintegration time. Table 3: Drug content, hardness, friability, disintegration time of sulfamethoxazole tablets formulated employing starch phosphate and crospovidone as disintegrant Disintegrant Type of addition & concentration Drug content Hardness Friability Disintegration time (Wet/Dry) (mg/tab) (Kg/cm 2 ) (min-sec) Wet (5%) 99.7 6.0 2.1 2-25 Starch Phosphate Wet (10%) 99.1 5.5 1.0 2-23 Dry (5%) 99.2 6.5 1.3 2-09 Dry (10%) 99.6 6.5 0.71 2-27 Wet (5%) 99.7 7.5 0.89 4-24 Crospovidone Wet (10%) 99.7 7.0 1.0 4-47 Dry (5%) 99.2 7.0 0.70 8-40 Dry (10%) 99.2 7.5 0.7 1-34 Commercial - 400.5 6.5 0.81 1-37 The dissolution parameters of the tablets prepared are summarised in Tables 4 and 5. The dissolution of both paracetamol and sulfamethoxazole from all the tablets prepared followed first order kinetics with correlation coefficient (R 2 ) greater than 0.855. All the dissolution parameters (PD 10, DE 30, T 50 and K 1 ) indicated very rapid and higher dissolution of the drug from tablets formulated employing starch phosphate as disintegrant when compared

Int. J. Chem. Sci.: 9(2), 2011 897 to those formulated with crospovidone and commercial product in each case. Wet addition of starch phosphate gave relatively faster dissolution with both the drugs than dry addition. Table 4: Dissolution parameters of paracetamol tablets formulated employing starch phosphate and crospovidone as disintegrant Disintegrant Type of addition & concentration (Wet/Dry) PD 10 T 50 (min.) DE 30 k 1 (min -1 ) Wet (5%) 72.22 < 5 min 71.40 0.0943 Starch Wet (10%) 80.49 < 5 min 79.27 0.1352 Phosphate Dry (5%) 55.43 6 min 58.70 0.0506 Dry (10%) 63.28 < 5 min 66.37 0.0673 Wet (5%) 51.85 9 min 65.17 0.0789 Crospovidone Wet (10%) 78.19 < 5 min 78.09 0.1054 Dry (5%) 66.60 < 5 min 71.20 0.0859 Dry (10%) 69.73 < 5 min 74.89 0.0915 Commercial - 49.19 11 min 54.94 0.0457 (PD 10 : Percent Dissolved in 10 min; T 50 : Time for 50% Dissolution; DE 30 : Dissolution Efficiency at 30 min; k 1 : First rder Dissolution Rate Constant) Table 5: Dissolution parameters of sulfamethoxazoletablets formulated employing starch phosphate and crospovidone as disintegrant Disintegrant Starch Phosphate Type of addition & concentration (Wet/Dry) PD 10 T 50 (min.) DE 30 k 1 (min -1 ) Wet (5%) 74.32 6 70.98 0.0869 Wet (10%) 79.50 < 5 75.28 0.1585 Dry (5%) 46.62 12 60.62 0.0683 Dry (10%) 64.68 6 62.83 0.0751 Cont

898 K. P. R. Chowdary et al.: Preparation and Evaluation. Disintegrant Crospovidone Type of addition & concentration (Wet/Dry) PD 10 T 50 (min.) DE 30 k 1 (min -1 ) Wet (5%) 65.44 6 68.66 0.0790 Wet (10%) 67.30 < 5 76.74 0.1490 Dry (5%) 23.04 23 29.96 0.0205 Dry (10%) 58.40 8 57.51 0.0691 Commercial - 41.80 16 40.11 0.0530 (PD 10 : Percent Dissolved in 10 min; T 50 : Time for 50% Dissolution; DE 30 : Dissolution Efficiency at 30 min; k 1 : First rder Dissolution Rate Constant) As the concentration of disintegrant was increased the dissolution rate was also increased. Dissolution of both paracetamol and sulfamethoxazole from the tablets formulated employing starch phosphate was much higher than the official specification (NLT 80 % in 30 min.). The fast disintegration and rapid and higher dissolution observed with the tablets formulated employing starch phosphate is due to its high swelling and easy dispersible nature. All the formulated tablets gave higher dissolution than the corresponding commercial brands. CNCLUSIN (i) (ii) (iii) (iv) Starch phosphate prepared by reacting potato starch with di-sodium hydrogen orthophosphate anhydrous at elevated temperatures was crystalline, non-hygroscopic and was insoluble in water and aqueous fluids of acidic and alkaline phs. It also exhibited good swelling (400%) in water. It has no pasting or gelling property when heated at 100 0 C in water for 30 min. Paracetamol and sulfamethoxazole tablets formulated employing starch phosphate (both wet and dry addition) disintegrated within 3 min. Wet addition of starch phosphate gave relatively fast disintegration than dry addition with both the drugs. Paracetamol and sulfamethoxazole tablets formulated employing starch phosphate as disintegrant gave rapid and higher dissolution of the contained drug when compared to those formulated with crospovidone and commercial product in each case. Wet addition of starch phosphate gave relatively faster dissolution with both the drugs than dry addition.

Int. J. Chem. Sci.: 9(2), 2011 899 (v) Thus starch phosphate, a new modified starch was found to be a promising disintegrant in tablet formulations and can be used in a concentration of 5-10 % as an efficient disintegrant. ACKNWLEDGEMENT Authors are thankful to University Grants Commission, New Delhi for providing financial assistance in the form of UGC JRF to Veeraiah Enturi. REFERENCES 1. K. P. R. Chowdary, Veeraiah Enturi and S. Sujatha, Int. J. Chem. Sci., 9(1), 177-187 (2010). 2.. B. Wurzburg, CRC Press. Inc., Boca Raton, Florida (1986) pp. 277. 3. T. E. Luallen, Food Technol., 48, 39 (1994). 4. E. Salay and C. F. Ciacco, Strach/Starke., 42, 15 (1990). 5. J. H. Sung, D. P. Park, B. J. Park, H. J. Choi and M. S. Jhon., Biomacromolecules., 6, 2182 (2005). Accepted : 03.01.2011